Latest News and Press Releases

EIB's InnovFin Financing Supports Innovative Companies under Horizon 2020 Financing to Support Manufacturing Facility Expansion and Development of Lead Product Candidates ATHLONE, Ireland, March...

ATHLONE, Ireland, March 19, 2015 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL), a global, commercial-stage, specialty pharmaceutical company that develops and manufactures a range of pharmaceutical...

ATHLONE, Ireland, March 18, 2015 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL) today announced that James Tursi, M.D., has been appointed chief medical officer. Dr. Tursi will be responsible for...

ATHLONE, Ireland, March 13, 2015 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL) (the "Company"), a global, commercial-stage, specialty pharmaceutical company that develops and manufactures a range of...

ATHLONE, Ireland, Dec. 8, 2014 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL) today announced that Tony Zook, formerly executive vice president, Global Commercial Operations, at AstraZeneca, has been...

ATHLONE, Ireland, Nov. 13, 2014 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL), a global, commercial-stage, specialty pharmaceutical company that develops and manufactures a range of pharmaceutical...

ATHLONE, Ireland, Nov. 6, 2014 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL) (the "Company"), a global, commercial-stage, specialty pharmaceutical company that develops and manufactures a range of...

ATHLONE, Ireland, Oct. 22, 2014 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL), a global, commercial-stage, specialty pharmaceutical company that develops and manufactures a range of pharmaceutical...

ATHLONE, Ireland, July 30, 2014 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL) (the "Company"), a global, commercial-stage, specialty pharmaceutical company that develops and manufactures a range of...

ATHLONE, Ireland, July 25, 2014 (GLOBE NEWSWIRE) -- Innocoll AG (the "Company"), a global, commercial-stage, specialty pharmaceutical company that develops and manufactures a range of pharmaceutical...